Therefore, we hypothesize that SFRP5/WNT5A pathway in adipose tissue might play an important role in NAFLD-related to obesity pathogenesis through the adipose tissue-liver axis. Here, SFRP5 is linked to metabolic dysfunction-associated steatotic liver disease.